These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10644791)

  • 1. Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis.
    Komiyama A; Arai H; Kijima M; Hirayama K
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):214-7. PubMed ID: 10644791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
    Mullaney P; Vajsar J; Smith R; Buncic JR
    Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of signs in ocular myasthenia gravis and correlation with acetylcholine receptor antibodies.
    Francis IC; Nicholson GA; Kappagoda MB
    Aust N Z J Ophthalmol; 1985 Nov; 13(4):395-9. PubMed ID: 3833299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validation of the ice pack test in ophthalmoparesis due to myasthenia gravis].
    Ramirez-Antunez ÁG; García-Ramos G; Estañol-Vidal B; Juárez-Flores A
    Rev Neurol; 2013 Nov; 57(9):385-95. PubMed ID: 24150950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases.
    McCreery KM; Hussein MA; Lee AG; Paysse EA; Chandran R; Coats DK
    Binocul Vis Strabismus Q; 2002; 17(3):181-6. PubMed ID: 12171588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood myasthenia gravis: clinical features and outcomes.
    Sri-udomkajorn S; Panichai P; Liumsuwan S
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis.
    Ozawa Y; Uzawa A; Kanai T; Oda F; Yasuda M; Kawaguchi N; Himuro K; Kuwabara S
    J Neurol Sci; 2019 Jul; 402():12-15. PubMed ID: 31100651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation of myasthenia gravis with voriconazole.
    Azzam R; Shaikh AG; Serra A; Katirji B
    Muscle Nerve; 2013 Jun; 47(6):928-30. PubMed ID: 23666793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study.
    Lindberg C; Andersen O; Lefvert AK
    Acta Neurol Scand; 1998 Jun; 97(6):370-3. PubMed ID: 9669469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decompensating esophoria as the presenting feature of myasthenia gravis.
    Arblaster GE; Shipman TL; Pepper IM
    J AAPOS; 2009 Jun; 13(3):310-1. PubMed ID: 19395293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraocular muscle responses to orbital cooling (ice test) for ocular myasthenia gravis diagnosis.
    Ellis FD; Hoyt CS; Ellis FJ; Jeffery AR; Sondhi N
    J AAPOS; 2000 Oct; 4(5):271-81. PubMed ID: 11040476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hickam's dictum: Myasthenia Gravis presenting concurrently with Graves' disease.
    Sehgal S; Rebello R; Wolmarans L; Elston M
    BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28882932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blepharoptosis in myasthenia gravis.
    Castronuovo S; Krohel GB; Kristan RW
    Ann Ophthalmol; 1983 Aug; 15(8):751-4. PubMed ID: 6660720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unilateral-external Ophthalmoplegia: ARare Presentation of Myasthenia Gravis.
    Khan MS; Habib A; Basit I
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):142-143. PubMed ID: 28666511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ice pack test for myasthenia gravis.
    Sethi KD; Rivner MH; Swift TR
    Neurology; 1987 Aug; 37(8):1383-5. PubMed ID: 3614664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular myasthenia gravis associated with euthyroid ophthalmopathy.
    Kusuhara T; Nakajima M; Imamura A
    Muscle Nerve; 2003 Dec; 28(6):764-6. PubMed ID: 14639594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Low-to-Moderate Dose Oral Corticosteroid Treatment in Ocular Myasthenia Gravis.
    Lee YG; Kim US
    J Pediatr Ophthalmol Strabismus; 2018 Sep; 55(5):339-342. PubMed ID: 30074608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis and associated autoimmune diseases in children.
    Tsao CY; Mendell JR; Lo WD; Luquette M; Rennebohm R
    J Child Neurol; 2000 Nov; 15(11):767-9. PubMed ID: 11108515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular Weakness in Myasthenia Gravis: Changes in Affected Muscles are a Distinct Clinical Feature.
    de Meel RHP; Raadsheer WF; van Zwet EW; Tannemaat MR; Verschuuren JJGM
    J Neuromuscul Dis; 2019; 6(3):369-376. PubMed ID: 31424417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
    Kupersmith MJ; Ying G
    Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.